Assessment of immune response to repeat stimulation with BCG vaccine using in vitro PBMC model

Journal of Immune Based Therapies and Vaccines

Volumn 8, Issue , 2010, Pages

  Kashyap, Rajpal S ^a   Husain, Aliabbas A ^a   Morey, Shweta H ^a   Panchbhai, Milind S ^a   Deshpande, Poonam S ^a   Purohit, Hemant J ^b   Taori, Girdhar M ^a   Daginawala, Hatim F ^a  

^a CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

^b NATIONAL ENVIRONMENTAL ENGINEERING RESEARCH INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DEAMINASE; BCG VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY;

ADULT; ARTICLE; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IN VITRO STUDY; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; T LYMPHOCYTE;

EID: 77954078774     PISSN: None     EISSN: 14768518     Source Type: Journal    
DOI: 10.1186/1476-8518-8-3     Document Type: Article

References (18)

1. Aronson NE, Santosham M, Comstock GW, Howard RS, Moulton LH, Rhoades ER, Harrison LH. Long-Term Efficacy of BCG Vaccine in American Indians and Alaska Natives - A 60-Year Follow-up Study. JAMA 2004, 291:2086-2091. 10.1001/jama.291.17.2086, 15126436.
2. Biet F, Kremer L, Wolowczuk I, Delacre M, Locht C. Mycobacterium bovis BCG Producing Interleukin-18 Increases Antigen-Specific Gamma Interferon Production in Mice. Infect Immun 2002, 70:6549-57. 10.1128/IAI.70.12.6549-6557.2002, 132979, 12438324.
3. Dietrich G, Viret JF, Hess J. Novel vaccination strategies based on recombinant Mycobacterium bovis BCG. Int J Med Microbiol 2003, 292:441-451. 10.1078/1438-4221-00227, 12635927.
4. Feng CG, Palendira U, Demange C, Spratt JM, Malin AS, Britton WJ. Priming by DNA Immunization Augments Protective Efficacy of Mycobacterium bovis Bacilli Calmette-Guerin against Tuberculosis. Infect Immu 2001, 69:4174-4176.
5. Ferraz JC, Stavropoulos E, Yang M, Coades S, Espitia C, Lowrie DB, Colston MJ, Tascon RE. A Heterologous DNA Priming-Mycobacterium bovis BCG Boosting Immunization Strategy Using Mycobacterial Hsp70, Hsp65, and Apa Antigens Improves Protection against Tuberculosis in Mice. Infect Immun 2004, 72:6945-6950. 10.1128/IAI.72.12.6945-6950.2004, 529122, 15557616.
6. Fine P, Carneiro I, Milstien J, Clements CJ. Report of Department of Vaccines and Other Biologicals. 1999, World Health Organization, Geneva, Switzerland.
7. Goonetilleke NP, McShane H, Hannan CM, Anderson RJ, Brookes RH, Hill AVS. Enhanced Immunogenicity and Protective Efficacy against Mycobacterium tuberculosis of Bacille Calmette-Guerin Vaccine Using Mucosal Administration and Boosting with a Recombinant Modified Vaccinia Virus Ankara. J Immunol 2003, 171:1602-1609.
8. Grode L, Seiler P, Baumann S, Hess J, Brinkmann V, Eddine AN, Mann P, Goosmann C, Bandermann S, Smith D, Bancroft GJ, Reyrat JM, Van Soolingen D, Raupach B, Kaufmann SHE. Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis Bacille Calmette-Guerin mutants that secrete listeriolysin. J Clin Invest 2005, 115:2472-2479. 10.1172/JCI24617, 1187936, 16110326.
9. Hess J, Miko D, Catic A, Lehmensiek V, Russell DG, Kaufmann SHE. Mycobacterium bovis Bacille Calmette-Guerin strains secreting listeriolysin of Listeria monocytogenes. Proc Natl Acad Sci USA 1998, 95:5299-5304. 10.1073/pnas.95.9.5299, 20255, 9560270.
10. Horwitz MA, Harth G, Dillon BJ, Galic SM. Enhancing the protective efficacy of Mycobacterium bovis BCG vaccination against tuberculosis by boosting with the Mycobacterium tuberculosis major secretory protein. Infect Immu 2005, 73:4676-83.
11. Menzies R, Vissandjee B, Rocher I, Germain YS. The Booster Effect in Two-Step Tuberculin Testing among Young Adults in Montreal. Ann Intern Med 1994, 120:190-198.
12. Murray PJ, Aldovinit A, Young RA. Manipulation and potentiation of antimycobacterial immunity using recombinant Bacille Calmette-Guerin strains that secrete cytokines. Proc Natl Acad Sci USA 1996, 93:934-939. 10.1073/pnas.93.2.934, 40162, 8570663.
13. Ponnighaus JM, Fine PEM, Sterne JAC, Wilson RJ, Msosa E, Gruer PJK, Jenkins PA, Lucas SB, Liomba G, Bliss L. Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi. Lancet 1992, 339:636-639. 10.1016/0140-6736(92)90794-4, 1347338.
14. Pulickal AS, Vincent G, Fernandez G. Comparison of the Prevalence of Tuberculosis Infection in BCG Vaccinated versus Non-Vaccinated School Age Children. Indian 2007, 44:344-347.
15. Pym AS, Brodin P, Majlessi L, Brosch R, Demangel C, Williams A, Griffiths KE, Marchal G, Leclerc C, Cole ST. Recombinant BCG Exporting ESAT-6 Confers Enhanced Protection Against Tuberculosis. Nat Med 2003, 9:533-539. 10.1038/nm859, 12692540.
16. Udani PM. Is Booster dose of BCG vaccine necessary?. Indian J Pediat 1989, 56:511-520.
17. Uyan AP, Baskin E, Buyukbese E, Gokalp AS. Evaluating Bacille Calmette Guerin vaccination by Tuberculin Skin Test Response. Indian Pediatr 2000, 37:1106-1110.
18. Zhu X, Venkataprasad N, Ivanyi J, Vordermeier HM. Vaccination with recombinant vaccinia viruses protects mice against Mycobacterium tuberculosis infection. Immunology 1997, 92:6-9. 10.1046/j.1365-2567.1997.00358.x, 1363974, 9370917.